Tempsens Instruments Sets October 31 Q2 FY27 Investor Call

Tempsens Instruments (India) Limited will hold an investor conference call at 2:00 pm IST on October 31, 2026, following its board meeting to consider Q2 FY27 and half-year results. The company last reported Q1 FY27 revenue of ₹119 crore, a 33.4% year-on-year increase, with net profit of ₹16.3 crore.

When will Tempsens Instruments announce and discuss Q2 FY27 results?

Tempsens Instruments will have its board consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, on October 30, 2026. The board meeting was disclosed to the BSE on October 26 and is the scheduled earnings date for the company’s second quarter of FY27.

The company has scheduled an earnings conference call for October 31 at 2:00 pm IST. Analysts and shareholders have been invited to hear management’s discussion of the Q2 FY27 financial performance and ask questions through the dial-in and registration arrangements provided by the company.

The call follows the board’s consideration of the results rather than an independently announced operating update. As of the information provided, the Q2 and H1 FY27 financial figures have not yet been disclosed. Investors will therefore be awaiting the board-approved statement and management commentary on the following day.

What other matters are on the October 30 board agenda?

Tempsens Instruments’ October 30 agenda also includes the proposed appointment of Mr. Aryan Rathi as an additional director and consideration of his remuneration. The board is additionally scheduled to consider the appointment of a Joint Statutory Auditor.

The company’s October 26 announcement also referred to ratification of its employee stock option plan, or ESOP. These agenda items sit alongside the review of unaudited standalone and consolidated results, meaning the board meeting covers both financial reporting and corporate governance matters.

The disclosure does not state that these appointments have been completed. Their status will depend on the board’s consideration at the scheduled meeting and any subsequent regulatory communication from the company.

How did Tempsens Instruments perform in the previous quarter?

Tempsens Instruments reported revenue of ₹119 crore in Q1 FY27, representing growth of 33.4% from the year-earlier quarter and a 10.7% decline from the preceding quarter. Net profit was ₹16.3 crore, up 16.2% year on year, while the operating margin was 20.0%.

The available quarterly comparison shows revenue of ₹89 crore in June 2025, ₹133 crore in March 2026 and ₹119 crore in June 2026. Operating profit moved from ₹17 crore in June 2025 to ₹25 crore in March 2026 and ₹20 crore in June 2026. All absolute figures in this comparison are stated in ₹ crore.

The comparison indicates that Q1 FY27 revenue remained materially above the June 2025 level despite declining from the March 2026 quarter. The October 30 results will provide the first reported view of whether the company’s July-September performance changed that quarterly trend.

Why are the Q2 FY27 results important for investors?

The Q2 FY27 release is important because it will provide results for both the September quarter and the first six months of the financial year. It will also be the first formal financial update since the Q1 FY27 result, when revenue growth was 33.4% year on year and net profit growth was 16.2% year on year.

Management had said during its May 30, 2026 earnings call that it remained confident of achieving double-digit revenue growth in FY27. It linked that view to an expanding order backlog and better execution in international markets. The Q2 statement and subsequent call may offer investors more information on progress against that stated objective.

The company has not provided a Q2 revenue, profit or margin estimate in the supplied disclosures. As a result, any assessment of the September-quarter outcome should await the unaudited results and management’s explanation of order execution, demand conditions and profitability.

How does the results schedule affect Tempsens Instruments shareholders?

Tempsens Instruments has closed its trading window from October 1, 2026, and stated that it will reopen 48 hours after the Q2 FY27 results are announced. Such closures are intended to restrict trading by designated persons while unpublished price-sensitive information is being considered and released.

For shareholders, the October 31 call offers a forum to seek clarification after the results announcement. The disclosed agenda allows participants to track the reported financial figures, management’s commentary on the FY27 growth outlook, and the board’s decisions on the proposed director and auditor-related matters.

No share-price movement, valuation data or market reaction was included in the provided material. The direct market-relevant events currently disclosed are the October 30 board meeting, the expected results announcement and the investor call scheduled for the following afternoon.

Conclusion

Tempsens Instruments is set to consider Q2 and H1 FY27 unaudited results on October 30, followed by a shareholder and analyst call on October 31. The prior quarter provides the main available financial reference point: ₹119 crore in revenue, ₹16.3 crore in net profit and a 20.0% operating margin in Q1 FY27.

The next disclosures to watch are the board-approved standalone and consolidated results, the company’s explanation of quarterly performance, and the outcome of the proposed additional director, Joint Statutory Auditor and ESOP-related matters. Management’s comments on its stated double-digit FY27 revenue-growth objective will also be relevant.